View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
  2. Company News
September 14, 2018

Deals this week: GE Global Research, Thermo Fisher Scientific, Bio2 Technologies

GE Global Research, a subsidiary of General Electric (GE), has partnered with Defense Advanced Research Projects Agency (DARPA) for a three-year research project valued at $2.9m.

GE Global Research, a subsidiary of General Electric (GE), has partnered with Defense Advanced Research Projects Agency (DARPA) for a three-year research project valued at $2.9m.

Free Report
img

What is driving M&A activity in the MedTech space?

The COVID-19 pandemic has left an indelible mark on the MedTech landscape. Changes in how healthcare is delivered, and new treatment modalities, are creating opportunities and challenges for both new and traditional players. As companies sought out opportunities during the pandemic-driven downturn, the number and value of mergers and acquisition deals in the MedTech space increased. Companies worked to reposition themselves in the newly aligned healthcare world, but with further economic turmoil expected: will these trends be repeated? And what tech areas should firms be looking to expand their capabilities into? GlobalData’s report, “Themes driving M&A activity in the Medical Devices Sector, Q1 2022,” draws upon GlobalData’s extensive MedTech deals databases, highlighting major trends and hot themes in M&A activity. This report will assist you in:
  • Understanding value and volume trends in M&A from Q1 2018 to Q1 2022
  • Understanding regional trends in M&A activity
  • Understanding which medical device sectors are leading M&A activity, and which are lagging
  • Understanding the leading tech trends in Q1 2022 M&A activity
  • Knowing the key deals that occurred during Q1 2022
Download the full report to understand what to expect and how to align your business for success.
by GlobalData
Enter your details here to receive your free Report.

The research project involves the development of new non-drug treatments for diabetes by using electronic medical devices. The devices will use technology, which stimulates metabolic biosystems to produce drug-like effects to treat diabetes.

Both GE Global Research and DARPA are research and development services firms based in the US.

The collaboration aims to develop a suitable alternative for treating diabetes with non-invasive medical devices, which causes less side effects compared to drug treatments.

Thermo Fisher Scientific has inked an agreement to acquire Becton, Dickinson and Company’s (BD) advanced bioprocessing business.

BD’s advanced bioprocessing business unit will be merged into Thermo Fisher’s Life Sciences Solutions Segment, as part of the agreement.

The transaction is expected to be closed in the first quarter of next year, subject to customary closing conditions.

Based in the US, Thermo Fisher is a medical devices developer, while BD, also based in the US, is a manufacturer of medical devices, instruments, and reagents.

“The company plans to use the funds raised to advance the development of its AltaValve™ Transcatheter Mitral Valve Replacement (TMVR) device.”

The transaction will enable the acquirer company to expand its bio-production offering and increase its development and production capabilities.

Bio2 Technologies Inc has closed a series C equity financing round, which involved the participation of DSM Venturing, a private equity investment firm based in the Netherlands.

Based in the US, Bio2 Technologies is engaged in the development of advanced ortho-biomaterials.

The company plans to use the funds for conducting a clinical study for its spine product, Vitrium®, which is a novel resorbable ortho-biomaterial used in musculo­skeletal surgery.

4C Medical Technologies (4C Medical) has raised $17m through the private placement of shares of its series A preferred stock.

Based in the US, 4C Medical is engaged in the development of minimally invasive therapies for structural heart diseases.

The company plans to use the funds raised to advance the development of its AltaValve™ Transcatheter Mitral Valve Replacement (TMVR) device, which allows replacement of mitral heart valves without the need for open-heart surgery.

Related Companies

Free Report
img

What is driving M&A activity in the MedTech space?

The COVID-19 pandemic has left an indelible mark on the MedTech landscape. Changes in how healthcare is delivered, and new treatment modalities, are creating opportunities and challenges for both new and traditional players. As companies sought out opportunities during the pandemic-driven downturn, the number and value of mergers and acquisition deals in the MedTech space increased. Companies worked to reposition themselves in the newly aligned healthcare world, but with further economic turmoil expected: will these trends be repeated? And what tech areas should firms be looking to expand their capabilities into? GlobalData’s report, “Themes driving M&A activity in the Medical Devices Sector, Q1 2022,” draws upon GlobalData’s extensive MedTech deals databases, highlighting major trends and hot themes in M&A activity. This report will assist you in:
  • Understanding value and volume trends in M&A from Q1 2018 to Q1 2022
  • Understanding regional trends in M&A activity
  • Understanding which medical device sectors are leading M&A activity, and which are lagging
  • Understanding the leading tech trends in Q1 2022 M&A activity
  • Knowing the key deals that occurred during Q1 2022
Download the full report to understand what to expect and how to align your business for success.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network